English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

Cortical and Striatal Circuits in Huntington's Disease

MPS-Authors
/persons/resource/persons243380

Blumenstock,  Sonja
Department: Molecules-Signaling-Development / Klein, MPI of Neurobiology, Max Planck Society;
Research Group: Molecular Neurodegeneration / Dudanova, MPI of Neurobiology, Max Planck Society;

/persons/resource/persons38808

Dudanova,  Irina
Research Group: Molecular Neurodegeneration / Dudanova, MPI of Neurobiology, Max Planck Society;

External Resource
No external resources are shared
Fulltext (public)

fnins-14-00082.pdf
(Publisher version), 3MB

Supplementary Material (public)
There is no public supplementary material available
Citation

Blumenstock, S., & Dudanova, I. (2020). Cortical and Striatal Circuits in Huntington's Disease. Frontiers in Neuroscience, 14: 82. doi:10.3389/fnins.2020.00082.


Cite as: http://hdl.handle.net/21.11116/0000-0005-DFE6-D
Abstract
Huntington's disease (HD) is a hereditary neurodegenerative disorder that typically manifests in midlife with motor, cognitive, and/or psychiatric symptoms. The disease is caused by a CAG triplet expansion in exon 1 of the huntingtin gene and leads to a severe neurodegeneration in the striatum and cortex. Classical electrophysiological studies in genetic HD mouse models provided important insights into the disbalance of excitatory, inhibitory and neuromodulatory inputs, as well as progressive disconnection between the cortex and striatum. However, the involvement of local cortical and striatal microcircuits still remains largely unexplored. Here we review the progress in understanding HD-related impairments in the cortical and basal ganglia circuits, and outline new opportunities that have opened with the development of modern circuit analysis methods. In particular, in vivo imaging studies in mouse HD models have demonstrated early structural and functional disturbances within the cortical network, and optogenetic manipulations of striatal cell types have started uncovering the causal roles of certain neuronal populations in disease pathogenesis. In addition, the important contribution of astrocytes to HD-related circuit defects has recently been recognized. In parallel, unbiased systems biology studies are providing insights into the possible molecular underpinnings of these functional defects at the level of synaptic signaling and neurotransmitter metabolism. With these approaches, we can now reach a deeper understanding of circuit-based HD mechanisms, which will be crucial for the development of effective and targeted therapeutic strategies.